3.70Open3.70Pre Close0 Volume5 Open Interest7.50Strike Price0.00Turnover303.82%IV-16.21%PremiumJul 19, 2024Expiry Date4.23Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9519Delta0.0733Gamma0.77Leverage Ratio-0.0078Theta-0.0010Rho-0.73Eff Leverage0.0005Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
loading...
No comment yet